APA (7th ed.) Citation

HL, G., S, N., C, T., M, M., J, B., G, I., . . . CH, B. (2016). A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study). Clinical breast cancer, 16(1), 38. https://doi.org/10.1016/j.clbc.2015.10.005

Chicago Style (17th ed.) Citation

HL, Gómez, et al. "A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)." Clinical Breast Cancer 16, no. 1 (2016): 38. https://doi.org/10.1016/j.clbc.2015.10.005.

MLA (9th ed.) Citation

HL, Gómez, et al. "A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)." Clinical Breast Cancer, vol. 16, no. 1, 2016, p. 38, https://doi.org/10.1016/j.clbc.2015.10.005.